Skip to main content
OpenTrials
Completed

NCT Number: NCT02184065

Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

Observational study to evaluate the efficacy and safety of meloxicam (Mobicox®) in Mexican population with rheumatic diseases

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arthritis, Rheumatoid Arthritis Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age of 12 or older and rheumatologic disease

Exclusion criteria

  • Hypersensitivity to meloxicam
  • Hypersensitivity to other Non-steroidal anti-inflammatory drugs (NSAIDS)
  • History of asthma, angioedema or urticaria secondary to NSAIDS
  • Pregnancy or lactation
  • Recent or current history of peptic ulcer disease, severe renal failure and severe hepatic failure

Treatment and study plan

Meloxicam

Drug

Primary outcomes

  1. Intensity of symptoms at rest evaluated with a 4-point scale

    Time frame: 30 and 90 days

  2. Intensity of symptoms during movement evaluated with a 4-point scale

    Time frame: 30 and 90 days

  3. Medical global evaluation on a 4-point scale

    Time frame: 30 and 90 days

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Clinical and Therapeutic Evaluation of Meloxicam in Mexican Patients With Rheumatic Diseases

Important dates

Study start
2004
Primary completion
2007
First posted
Jul 9, 2014
Registry last updated
Jul 9, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.